AURESINE® selectively eliminates Staphylococcus leaving natural microflora unharmed

Auresine eliminates Staphylococcus aureus being particularly vicious against strains that are resistant to antibiotics, such as MRSA, leaving natural microflora unharmed. Auresine cleaves cell walls of a wide range of Staphylococcus strains. As a result of the cleavage bacteria lose its innate protection and disintegrate. Auresine effectively kills also those Staphylococcus strains, which have already formed densely packed layer, so called biofilm, particularly resistant to antibiotic treatment.

Auresine key features:

effective – microgram of enzyme eliminates millions of bacteria in minutes

selective – kills staphylococcus but saves natural microflora

universal – acts on antibiotic resistant strains (MRSA) and biofilms

kills on contact – no dilution effect

low propensity for resistance

safe – non-cytotoxic, non-mutagenic, non-corrosive, environment friendly

stable – can be stored for years

affordable – efficient production technology

stable – can be stored for years

AURESINE® mechanism of action

Auresine is a peptidoglycan hydrolase – enzyme which recognizes staphylococcal cells (pentaglycine cross-bridges, characteristic component of staphylococcal peptidoglycan mesh) and cleaves it leading to instant disintegration of the cell walls and cell death.

Auresine technology is protected by patent (EP 12722933,4, CA 2,833,335, AU 2012246763, US 14/056,432).